INDOBORAX Q2 FY26 Net Profit Jumps to ₹1,626.15 Lakh, Boosted by Operations & Asset Sale
Indo Borax & Chemicals reported significantly higher standalone and consolidated net profits for Q2 FY26, reaching ₹1,609.06 lakh and ₹1,626.15 lakh respectively, boosted by operational performance and a ₹934.72 lakh profit from asset sale.
The announcement of strong quarterly financial results, including a significant increase in net profit and revenue, along with a notable exceptional gain, is a key indicator of the company's financial health and will likely have a high impact on its share price and investor confidence.
The company reported a substantial increase in both standalone and consolidated net profits for the quarter ended September 30, 2025, driven by higher revenue from operations and a significant exceptional gain from the sale of office premises.
Indo Borax & Chemicals Limited announced the outcome of its Board Meeting held on November 11, 2025, where the Standalone and Consolidated Unaudited Financial Results for the Quarter and Half Year Ended September 30, 2025, were approved. * Standalone Financial Highlights for Q2 FY26 (compared to Q2 FY25): * Revenue from operations increased to ₹5,784.78 lakh from ₹3,787.45 lakh. * Total income rose to ₹6,119.11 lakh from ₹4,201.33 lakh. * Net Profit for the period significantly increased to ₹1,609.06 lakh from ₹902.87 lakh. * Basic & Diluted Earnings Per Share (EPS) was ₹5.01 compared to ₹2.81. * Consolidated Financial Highlights for Q2 FY26 (compared to Q2 FY25): * Revenue from operations increased to ₹5,784.78 lakh from ₹3,787.45 lakh. * Total income rose to ₹6,142.01 lakh from ₹4,222.25 lakh. * Net Profit for the period significantly increased to ₹1,626.15 lakh from ₹918.18 lakh. * Basic & Diluted Earnings Per Share (EPS) was ₹5.07 compared to ₹2.86. * An exceptional item of ₹934.72 lakh, representing profit on the sale of office premises, was reported for the quarter ended September 30, 2025. * The statutory auditors have carried out a Limited Review of the results and issued an unmodified review report. * The company operates in a single segment, "Manufacturing and selling of Chemicals".
What to do with a filing like this
Indo Borax & Chemicals Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Indo Borax & Chemicals Limited. Read the original for the full detail.